Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
暂无分享,去创建一个
Eric Boerwinkle | Len A Pennacchio | Jonathan C. Cohen | Wu Yin | Stefano Romeo | E. Boerwinkle | L. Pennacchio | H. Hobbs | S. Romeo | Julia Kozlitina | J. Kozlitina | Helen H Hobbs | Jonathan C Cohen | W. Yin
[1] S. Wattler,et al. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. , 1999, Genomics.
[2] Kenichi Yoshida,et al. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.C200010-JLR200 , 2002, Journal of Lipid Research.
[3] Jonathan C. Cohen,et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. , 2006, American journal of human genetics.
[4] Kenichi Yoshida,et al. Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3) , 2003, Journal of Biological Chemistry.
[5] Alexander Pertsemlidis,et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.
[6] H. Lodish,et al. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.
[7] Shamil R Sunyaev,et al. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.
[8] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[9] T. Olivecrona,et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.
[10] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[11] P. Nilsson-ehle,et al. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. , 1976, Journal of lipid research.
[12] Kenichi Yoshida,et al. ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase* , 2002, The Journal of Biological Chemistry.
[13] Guoqing Yang,et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4 Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400138-JLR200 , 2004, Journal of Lipid Research.
[14] Kang Ying,et al. Identification of a novel human angiopoietin-like gene expressed mainly in heart , 2003, Journal of Human Genetics.
[15] L. Havekes,et al. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400301-JLR200 , 2005, Journal of Lipid Research.
[16] J. Cha,et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4 Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.M500005-JLR200 , 2005, Journal of Lipid Research.
[17] Cai Li. Genetics and regulation of angiopoietin-like proteins 3 and 4 , 2006, Current opinion in lipidology.
[18] Jonathan C. Cohen,et al. Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.
[19] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[20] C. Fraser,et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.
[21] R. Eckel,et al. Lipoprotein lipase : genetics , lipid uptake , and regulation , 2002 .
[22] Warren C. Lathe,et al. Prediction of deleterious human alleles. , 2001, Human molecular genetics.
[23] T. Fujiwara,et al. Angptl3 regulates lipid metabolism in mice , 2002, Nature Genetics.
[24] ShizuyaYamashita,et al. Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase , 2007 .
[25] T. Suda,et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance , 2005, Nature Medicine.
[26] Guoqing Yang,et al. Oligomerization and Regulated Proteolytic Processing of Angiopoietin-like Protein 4* , 2004, Journal of Biological Chemistry.
[27] Eric Boerwinkle,et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.
[28] R. Collins,et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.
[29] J. Xu,et al. Cloning, expression and characterization of a novel human REPS1 gene. , 2001, Biochimica et biophysica acta.
[30] Ronald M Peshock,et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.
[31] D. Rader,et al. Characterization of the lipolytic activity of endothelial lipase. , 2002, Journal of lipid research.
[32] Jian Xu,et al. Identification of a novel human doublecortin-domain-containing gene (DCDC1) expressed mainly in testis , 2003, Journal of Human Genetics.
[33] B. Spiegelman,et al. Peroxisome Proliferator-Activated Receptor γ Target Gene Encoding a Novel Angiopoietin-Related Protein Associated with Adipose Differentiation , 2000, Molecular and Cellular Biology.
[34] D. Rader,et al. Hepatic proprotein convertases modulate HDL metabolism. , 2007, Cell metabolism.
[35] Jonathan C. Cohen,et al. Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes , 2008, Human molecular genetics.
[36] P. Chambon,et al. Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene* , 2000, The Journal of Biological Chemistry.
[37] Jonathan C. Cohen,et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.